#USA #Milford #Mass Spectrometry #Xevo MRT P10 #Multiomics Research

Waters Launches Innovative Xevo MRT P10 Mass Spectrometer

On June 1, 2026, at the 74th ASMS Conference on Mass Spectrometry and Allied Topics, Waters Corporation proudly introduced the Xevo MRT P10 Mass Spectrometer, which promises to redefine standards in benchtop high-resolution mass spectrometry (HRMS). Designed specifically for high-throughput multiomics, bioanalysis, and biopharmaceutical laboratories, this cutting-edge system enhances both the sensitivity and speed of mass spectrometric analysis.

Key Features of the Xevo MRT P10 MS

The Xevo MRT P10 MS boasts an impressive 20-fold increase in MS/MS sensitivity compared to its predecessor. This advancement enables researchers to gather deeper biological insights that are crucial for next-generation multiomics research, therapeutic endeavors, and high-throughput workflows. The system's efficiency is not just limited to sensitivity; it also features acquisition speeds that are twice as fast, streamlining processes and enhancing data collection in a way that was previously unattainable.

In the realm of lipidomics, the Xevo MRT P10 distinguishes itself further by identifying up to 40% more lipids through its LC-MS/MS capabilities than any leading alternative benchtop mass spectrometer. This improvement significantly contributes to the understanding of diseases at a molecular level, pushing the boundaries of what current technologies can achieve.

Additionally, the system is equipped with the DESI XS source, which sets a new benchmark for throughput in high-resolution spatial analysis. This technology allows for higher-confidence studies related to disease progression and treatment responses, reinforcing the role of the Xevo MRT P10 in cutting-edge biomedical research.

Addressing Research Challenges

Dr. James Hallam, Vice President and General Manager of Liquid Chromatography-Mass Spectrometry at Waters, remarks, “With the Xevo MRT P10 MS, we are elevating the expectations for what benchtop high-resolution mass spectrometry can accomplish.” The system is built to tackle the critical bottlenecks faced by researchers who require high-quality MS/MS data at unprecedented speeds.

As modern workflows demand rapid analytical insights, the Xevo MRT P10 rises to the challenge by providing an exceptional resolution, mass accuracy, and data quality, empowering researchers to draw confident conclusions from their work.

Dr. Corey Broeckling, Director of the Bioanalysis and Omics Center at Colorado State University, emphasizes the practical benefits of the Xevo MRT P10: “Its remarkable MS/MS sensitivity and fast acquisition rates have transformed our multiomics research capabilities. The ability to separate signals of similar mass at high speeds has significantly enhanced our data quality and versatility across a wide array of omics applications.”

Future Prospects in Multiomics

The Xevo MRT P10 is poised for future advancements across various fields within multiomics, including proteomics, lipidomics, and metabolomics, alongside significant applications in biopharmaceutical analysis and drug discovery. Such enhancements are expected to foster deeper biological interpretations and more comprehensive understandings of diseases, all driving forward the quest for effective therapies and diagnostics in healthcare.

Expected to be available globally by summer 2026, the Xevo MRT P10 MS will be a focal point at ASMS 2026. Researchers eager to learn more or request a demonstration can explore the product page on Waters Corporation’s official website.

Conclusion

As the world of science and technology continues to evolve, the breakthroughs brought by Waters Corporation through the introduction of the Xevo MRT P10 MS represent a significant leap towards comprehensive, high-quality analysis in multiomics research. This reflects Chapman’s commitment to innovation, helping researchers translate scientific challenges into life-enhancing solutions.

For additional information on this revolutionary product, visit Waters Corporation.